Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 3 publications
Real world experience: Examining outcomes using letermovir for CMV prophylaxis in high-risk allogeneic hematopoietic stem cell patients in the setting of using T-cell depletion as GVHD prophylaxis.
Journal: Transplant immunology
Published: September 15, 2022
First Report of Severe Acute Graft-Versus-Host Disease After Allogeneic Stem Cell Transplant in a Patient With Myelodysplastic Syndrome Treated With Atezolizumab: Literature Review.
Journal: World journal of oncology
Published: February 06, 2020
Increased risk of 100-day and 1-year infection-related mortality and complications in haploidentical stem cell transplantation.
Journal: Journal of blood medicine
Published: January 10, 2019
Showing 1-3 of 3
Last Updated: 09/26/2026